The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Amy D. Klion

National Institute of Allergy and Infectious Diseases

Laboratory of Parasitic Diseases

National Institutes of Health

Bethesda

USA

[email]@nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • National Institute of Allergy and Infectious Diseases, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, USA. 2003 - 2009
  • Bldg 4, Rm 126, National Institutes of Health, Bethesda. 2004
  • Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. 1999 - 2003

References

  1. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. Ogbogu, P.U., Bochner, B.S., Butterfield, J.H., Gleich, G.J., Huss-Marp, J., Kahn, J.E., Leiferman, K.M., Nutman, T.B., Pfab, F., Ring, J., Rothenberg, M.E., Roufosse, F., Sajous, M.H., Sheikh, J., Simon, D., Simon, H.U., Stein, M.L., Wardlaw, A., Weller, P.F., Klion, A.D. J. Allergy Clin. Immunol. (2009) [Pubmed]
  2. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Klion, A. Annu. Rev. Med. (2009) [Pubmed]
  3. Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing. Klion, A.D., Robyn, J., Maric, I., Fu, W., Schmid, L., Lemery, S., Noel, P., Law, M.A., Hartsell, M., Talar-Williams, C., Fay, M.P., Dunbar, C.E., Nutman, T.B. Blood (2007) [Pubmed]
  4. Approach to the therapy of hypereosinophilic syndromes. Klion, A.D. Immunol. Allergy. Clin. North. Am (2007) [Pubmed]
  5. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Klion, A.D., Robyn, J., Akin, C., Noel, P., Brown, M., Law, M., Metcalfe, D.D., Dunbar, C., Nutman, T.B. Blood (2004) [Pubmed]
  6. Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection. Klion, A.D., Vijaykumar, A., Oei, T., Martin, B., Nutman, T.B. J. Infect. Dis. (2003) [Pubmed]
  7. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Klion, A.D., Noel, P., Akin, C., Law, M.A., Gilliland, D.G., Cools, J., Metcalfe, D.D., Nutman, T.B. Blood (2003) [Pubmed]
  8. Albendazole therapy for loiasis refractory to diethylcarbamazine treatment. Klion, A.D., Horton, J., Nutman, T.B. Clin. Infect. Dis. (1999) [Pubmed]
 
WikiGenes - Universities